Top

Journal of Clinical Immunology

Published in:

01-05-2018 | Letter to Editor

Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis Despite IRAK-4 Deficiency

Authors: Boris Hügle, Norman Händel, Klaus Schwarz, Michael Borte, Volker Schuster

Published in: Journal of Clinical Immunology | Issue 4/2018

Excerpt

To the editor, …

Lin YT, Wang CT, Gershwin ME, Chiang BL. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev. 2011;10(8):482–9. https://doi.org/10.1016/j.autrev.2011.02.001.CrossRefPubMed

Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38(1):129–43. https://doi.org/10.1007/s10875-017-0465-8.CrossRefPubMed

Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol. 2004;16(1):34–41.CrossRefPubMed

Isnardi I, Ng YS, Srdanovic I, Motaghedi R, Rudchenko S, von Bernuth H, et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity. 2008;29(5):746–57. https://doi.org/10.1016/j.immuni.2008.09.015.CrossRefPubMedPubMedCentral

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.PubMed

Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003;299(5615):2076–9. https://doi.org/10.1126/science.1081902.CrossRefPubMed

Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, et al. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore). 2010;89(6):403–25. https://doi.org/10.1097/MD.0b013e3181fd8ec3.CrossRef

Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007;204(10):2407–22. https://doi.org/10.1084/jem.20070628.CrossRefPubMedPubMedCentral

Maglione PJ, Simchoni N, Black S, Radigan L, Overbey JR, Bagiella E, et al. IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens. Blood. 2014;124(24):3561–71. https://doi.org/10.1182/blood-2014-07-587824.CrossRefPubMedPubMedCentral

10.

Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol. 2011;29:447–91. https://doi.org/10.1146/annurev-immunol-030409-101335.CrossRefPubMed

11.

Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med. 2007;13(5):543–51. https://doi.org/10.1038/nm1590.CrossRefPubMed

12.

Staschke KA, Dong S, Saha J, Zhao J, Brooks NA, Hepburn DL, et al. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease. J Immunol. 2009;183(1):568–77. https://doi.org/10.4049/jimmunol.0802361.CrossRefPubMedPubMedCentral

13.

Comeau JL, Lin TJ, Macken MB, Li B, Ku CL, von Bernuth H, et al. Staphylococcal pericarditis, and liver and paratracheal abscesses as presentations in two new cases of interleukin-1 receptor associated kinase 4 deficiency. Pediatr Infect Dis J. 2008;27(2):170–4. https://doi.org/10.1097/INF.0b013e318157ad01.PubMedCrossRef

14.

Frans G, Moens L, Schrijvers R, Wuyts G, Bouckaert B, Schaballie H, et al. PID in disguise: molecular diagnosis of IRAK-4 deficiency in an adult previously misdiagnosed with autosomal dominant hyper IgE syndrome. J Clin Immunol. 2015;35(8):739–44. https://doi.org/10.1007/s10875-015-0205-x.CrossRefPubMed

15.

Gobin K, Hintermeyer M, Boisson B, Chrabieh M, Gandil P, Puel A, et al. IRAK4 deficiency in a patient with recurrent pneumococcal infections: case report and review of the literature. Front Pediatr. 2017;5:83. https://doi.org/10.3389/fped.2017.00083.CrossRefPubMedPubMedCentral

16.

Grazioli S, Hamilton SJ, McKinnon ML, Del Bel KL, Hoang L, Cook VE, et al. IRAK-4 deficiency as a cause for familial fatal invasive infection by Streptococcus pneumoniae. Clin Immunol. 2016;163:14–6. https://doi.org/10.1016/j.clim.2015.12.007.CrossRefPubMed

17.

Kallinich T, Kolsch U, Lieber M, Unterwalder N, Spors B, Lorenz M, et al. Septic arthritis or juvenile idiopathic arthritis—the case of a 2 year old boy. Pediatr Allergy Immunol. 2015;26(4):389–91. https://doi.org/10.1111/pai.12373.CrossRefPubMed

18.

McKelvie B, Top K, McCusker C, Letenyi D, Issekutz TB, Issekutz AC. Fatal pneumococcal meningitis in a 7-year-old girl with interleukin-1 receptor activated kinase deficiency (IRAK-4) despite prophylactic antibiotic and IgG responses to Streptococcus pneumoniae vaccines. J Clin Immunol. 2014;34(3):267–71. https://doi.org/10.1007/s10875-014-9996-4.CrossRefPubMed

19.

Pidgeon TE, Ahmad F, Hackett S, Rodrigues D, Nishikawa H. Management of a transcranial abscess secondary to interleukin-1 receptor associated kinase 4 deficiency. J Craniofac Surg. 2015;26(1):e2–3. https://doi.org/10.1097/SCS.0000000000001184.CrossRefPubMed

20.

Schondorf D, von Bernuth H, Simon A, Schneider G, Kolsch U, Schwarz K, et al. Liver abscess complicated by diaphragm perforation and pleural empyema leads to the discovery of interleukin-1 receptor-associated kinase 4 deficiency. Pediatr Infect Dis J. 2014;33(7):767–9. https://doi.org/10.1097/INF.0000000000000277.CrossRefPubMed

21.

Stergiopoulou T, Walsh TJ, Seghaye MC, Netea MG, Casanova JL, Moutschen M, et al. Deficiency of interleukin-1 receptor-associated kinase 4 presenting as fatal Pseudomonas aeruginosa bacteremia in two siblings. Pediatr Infect Dis J. 2015;34(3):299–300. https://doi.org/10.1097/INF.0000000000000550.CrossRefPubMed

22.

Takada H, Ishimura M, Takimoto T, Kohagura T, Yoshikawa H, Imaizumi M, et al. Invasive bacterial infection in patients with interleukin-1 receptor-associated kinase 4 deficiency: case report. Medicine (Baltimore). 2016;95(4):e2437. https://doi.org/10.1097/MD.0000000000002437.CrossRef

23.

Shichijo K, Ogose T, Kubota M, Tomimoto A, Kondo R, Taniguchi T, et al. Recurrent Staphylococcus aureus abscess and fatal pneumococcal septicemia due to IRAK-4 deficiency. Pediatr Int. 2015;57(6):1166–9. https://doi.org/10.1111/ped.12722.CrossRefPubMed

24.

Kelly PN, Romero DL, Yang Y, Shaffer AL 3rd, Chaudhary D, Robinson S, et al. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. J Exp Med. 2015;212(13):2189–201. https://doi.org/10.1084/jem.20151074.CrossRefPubMedPubMedCentral

25.

Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997;40(12):2105–15. https://doi.org/10.1002/1529-0131(199712)40:12<2105::AID-ART2>3.0.CO;2-B.CrossRefPubMed

26.

Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 2000;43(4):765–74. https://doi.org/10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B.CrossRefPubMed

27.

Kamphuis S, Hrafnkelsdottir K, Klein MR, de Jager W, Haverkamp MH, van Bilsen JH, et al. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Arthritis Res Ther. 2006;8(6):R178. https://doi.org/10.1186/ar2088.CrossRefPubMedPubMedCentral

28.

Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 2008;58(3):875–87. https://doi.org/10.1002/art.23291.CrossRefPubMedPubMedCentral

29.

Olivito B, Simonini G, Ciullini S, Moriondo M, Betti L, Gambineri E, et al. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J Rheumatol. 2009;36(9):2017–24. https://doi.org/10.3899/jrheum.090066.CrossRefPubMed

30.

Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 2005;52(3):826–32. https://doi.org/10.1002/art.20945.CrossRefPubMed

31.

Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(1):267–75. https://doi.org/10.1002/art.30076.CrossRefPubMed

32.

Nordal E, Songstad NT, Rygg M. Difficulties in defining antinuclear antibody-positive patients as a separate category in the classification of juvenile idiopathic arthritis: comment on the article by Ravelli et al. Arthritis Rheum. 2011;63(9):2835; author reply −6. https://doi.org/10.1002/art.30480.CrossRefPubMed

33.

Picard C, Casanova JL, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency. Clin Microbiol Rev. 2011;24(3):490–7. https://doi.org/10.1128/CMR.00001-11.CrossRefPubMedPubMedCentral

34.

Kanakoudi-Tsakalidou F, Pardalos G, Pratsidou-Gertsi P, Kansouzidou-Kanakoudi A, Tsangaropoulou-Stinga H. Persistent or severe course of reactive arthritis following Salmonella enteritidis infection. A prospective study of 9 cases. Scand J Rheumatol. 1998;27(6):431–4.CrossRefPubMed

35.

Mills KH. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol. 2011;11(12):807–22. https://doi.org/10.1038/nri3095.CrossRefPubMed

36.

Wexler AG, Frielle C, Berry G, Budgeon LR, Baccon J, Christensen ND, et al. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis. J Neuroimmunol. 2013;255(1–2):60–9. https://doi.org/10.1016/j.jneuroim.2012.11.004.CrossRefPubMed

Title: Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis Despite IRAK-4 Deficiency
Authors: Boris Hügle
Norman Händel
Klaus Schwarz
Michael Borte
Volker Schuster
Publication date: 01-05-2018
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 4/2018
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-018-0501-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2018

Cerebral Lymphoproliferation in a Patient with Kabuki Syndrome

Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome

Novel LRBA Mutation and Possible Germinal Mosaicism in a Slavic Family

Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency

Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation

Editorial

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials